rivaroxaban and HIV-Infections

rivaroxaban has been researched along with HIV-Infections* in 2 studies

Other Studies

2 other study(ies) available for rivaroxaban and HIV-Infections

ArticleYear
Use of Apixaban in Atrial Fibrillation With Ritonavir-Boosted Antiretroviral Therapy: A Case Report.
    Journal of pharmacy practice, 2023, Volume: 36, Issue:3

    Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; HIV Infections; Humans; Male; Pyridones; Ritonavir; Rivaroxaban; Stroke; Warfarin

2023
Gastrointestinal bleeding associated with rivaroxaban administration in a treated patient infected with human immunodeficiency virus.
    Swiss medical weekly, 2014, Jan-22, Volume: 144

    The use of rivaroxaban in fixed dosing regimens without need for routine coagulation monitoring may lead to the misconception that there is a minimal risk of drug-drug interactions. We describe the case of a patient infected with human immunodeficiency virus (HIV) on salvage therapy who developed gastrointestinal bleeding while receiving the standard dose of rivaroxaban for the prevention of venous thromboembolism after surgery. This case clearly sends a warning that protease inhibitors should not be co-administered with rivaroxaban. Furthermore, it highlights the importance of clinicians' caution about potential drug-drug interactions.

    Topics: Ankle Fractures; Anticoagulants; Darunavir; Drug Interactions; Gastrointestinal Hemorrhage; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Morpholines; Ritonavir; Rivaroxaban; Sulfonamides; Thiophenes

2014